Page last updated: 2024-11-07

penicillamine and Low Bone Density

penicillamine has been researched along with Low Bone Density in 1 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Research Excerpts

ExcerptRelevanceReference
"The prevalence of osteopenia and osteoporosis in children with WD was found as 22."1.35Bone mineral density of children with Wilson disease: efficacy of penicillamine and zinc therapy. ( Doneray, H; Ertekin, V; Selimoglu, MA; Yildirim, M, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Selimoglu, MA1
Ertekin, V1
Doneray, H1
Yildirim, M1

Other Studies

1 other study available for penicillamine and Low Bone Density

ArticleYear
Bone mineral density of children with Wilson disease: efficacy of penicillamine and zinc therapy.
    Journal of clinical gastroenterology, 2008, Volume: 42, Issue:2

    Topics: Adolescent; Bone Density; Bone Diseases, Metabolic; Chelating Agents; Child; Child, Preschool; Femal

2008